Recent Security Class Actions

Aldeyra Therapeutics Inc. Common Stock (NASDAQ: ALDX)

38 Days left to seek lead plaintiff status.

Company Name:Aldeyra Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: ALDX
Class Period Start:11/03/2023
Class Period End (inclusive):03/16/2026
Filing Deadline:05/29/2026

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) The results of the reproxalap (an Aldeyra drug candidate) clinical trials were inconsistent; (2) the inconsistency of the results rendered any purported positive findings from these trials unreliable and not meaningful; and (3) as a result, defendants’ statements about Aldeyra’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Aldeyra Therapeutics Inc. Common Stock (NASDAQ: ALDX) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address